Cadenza Bio Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$2.44M
- Investors
-
7
Cadenza Bio General Information
Description
Developer of small-molecule therapeutics designed to treat demyelinating and inflammatory diseases. The company offers a pipeline of orally administered drug candidates that address inflammation and support remyelination, enabling patients with demyelinating and inflammatory conditions to slow disease progression, promote repair, and improve daily functioning.
Contact Information
Website
www.cadenza.bioCorporate Office
- 600 N Robinson Avenue
- Suite 632
- Oklahoma City, OK 73102
- United States
Corporate Office
- 600 N Robinson Avenue
- Suite 632
- Oklahoma City, OK 73102
- United States
Cadenza Bio Timeline
Cadenza Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Debt - General | 28-Aug-2025 | $2.44M | Completed | Pre-Clinical Trials | ||
| 3. Seed Round | 05-Dec-2023 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
Cadenza Bio Comparisons
Industry
Financing
Details
Cadenza Bio Competitors (3)
One of Cadenza Bio’s 3 competitors is Contineum Therapeutics, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Contineum Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Athos Therapeutics | Venture Capital-Backed | Los Angeles, CA | ||||
| Edesa Biotech | Formerly VC-backed | Markham, Canada |
Cadenza Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cadenza Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cadenza Bio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boyd Street Ventures | Venture Capital | Minority | ||
| Cortado Ventures | Venture Capital | Minority | ||
| Illinois Ventures | Venture Capital | Minority | ||
| Oklahoma Life Science Fund | Venture Capital | Minority | ||
| Plains Ventures | Venture Capital | Minority |
Cadenza Bio FAQs
-
When was Cadenza Bio founded?
Cadenza Bio was founded in 2022.
-
Where is Cadenza Bio headquartered?
Cadenza Bio is headquartered in Oklahoma City, OK.
-
What is the size of Cadenza Bio?
Cadenza Bio has 5 total employees.
-
What industry is Cadenza Bio in?
Cadenza Bio’s primary industry is Biotechnology.
-
Is Cadenza Bio a private or public company?
Cadenza Bio is a Private company.
-
What is Cadenza Bio’s current revenue?
The current revenue for Cadenza Bio is .
-
How much funding has Cadenza Bio raised over time?
Cadenza Bio has raised $4.88M.
-
Who are Cadenza Bio’s investors?
Boyd Street Ventures, Cortado Ventures, Illinois Ventures, Oklahoma Life Science Fund, and Plains Ventures are 5 of 7 investors who have invested in Cadenza Bio.
-
Who are Cadenza Bio’s competitors?
Contineum Therapeutics, Athos Therapeutics, and Edesa Biotech are competitors of Cadenza Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
